Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-04-02

FDA Approved: FESOTERODINE FUMARATE — Supplemental Application (Camber Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved Camber Pharmaceuticals' supplemental application for fesoterodine fumarate (ANDA 204792).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fesoterodine fumarate (fesoterodine fumarate)

Snippet

SUPPL AP for FESOTERODINE FUMARATE (FESOTERODINE FUMARATE)